Pharmaceutical intermediates
Baloxavir Marboxil Intermediates
4 pharmaceutical intermediates for Baloxavir Marboxil. Indication: Influenza A Virus Infection; Influenza Virus Infection; Influenza B Virus Infection.
About Baloxavir Marboxil
- Originator
- Shionogi & Co., Ltd.
- Indication
- Influenza A Virus Infection; Influenza Virus Infection; Influenza B Virus Infection
- Approved Date
- 10/24/2018
- DS/DP
- 06/14/2030
Available intermediates
4 intermediates currently listed for Baloxavir Marboxil. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| N-[2-[[[2-(2,2-dimethoxyethoxy)ethyl]amino]carbonyl]-4-oxo-3-(phenylmethoxy)-1(4H)-pyridinyl]-Carbamic acid 1,1-dimethylethyl ester | 2136287-61-9 | / | / |
| (R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione | 1985607-70-2 | / | / |
| 7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol | 1985607-83-7 | / | / |
| 7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | 1370250-39-7 | / | / |
Building toward Baloxavir Marboxil?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →